Chlorothiazide Sodium (Akorn, Inc.)


Welcome to the PulseAid listing for the Chlorothiazide Sodium drug offered from Akorn, Inc.. This Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Akorn, Inc.
NON-PROPRIETARY NAME: Chlorothiazide Sodium
SUBSTANCE NAME: CHLOROTHIAZIDE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2012-08-13
END MARKETING DATE: 0000-00-00


Chlorothiazide Sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionChlorothiazide Sodium from Akorn, Inc.
LABELER NAME: Akorn, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/1)
START MARKETING DATE: 2012-08-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17478-419_8b346dfd-230e-4988-acf0-b460910ac138
PRODUCT NDC: 17478-419
APPLICATION NUMBER: NDA011145

Other CHLOROTHIAZIDE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Chlorothiazide Sodium
American Regent, Inc.Chlorothiazide Sodium
Fresenius Kabi USA, LLCChlorothiazide
Mylan Institutional LLCchlorothiazide sodium
Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.)Sodium Diuril
Sagent Pharmaceuticalschlorothiazide sodium